FdaApplication
ANDA 211832
Identifiers
- fda_app_no: ANDA211832
Properties
| Property | Value |
|---|---|
| applicant_name | TWI PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2020-06-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TERBUTALINE SULFATE | TERBUTALINE SULFATE | 5MG | TABLET;ORAL |
| TERBUTALINE SULFATE | TERBUTALINE SULFATE | 2.5MG | TABLET;ORAL |
2 products